|
Market Closed -
Nasdaq
00:00:00 22/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.090 USD | +1.87% |
|
+3.91% | -65.93% |
| 08-07 | Revelation Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-11 | Revelation Biosciences Adopts Stockholder Rights Plan | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
REVB 1.090 $
+1.87%
9.87K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| REVB | 1.090USD | +1.87% | 9.87K $ | |
CBOE
| REVB | 1.120USD | +2.75% | 249.76 $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 1.18 | 1.18 | 2.388 |
| Spread/Res. | -7.63% | -7.63% | -54.35% |
| Spread/Supp. | +14.74% | +14.74% | +14.74% |
| Support | 0.95 | 0.95 | 0.95 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- REVB Stock
- Charts Revelation Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
